| NCT ID | NCT05256251 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Westlake University |
| Condition | Aging |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,800 participants |
| Start Date | 2021-11-15 |
| Primary Completion | 2028-11-14 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,800 participants in total. It began in 2021-11-15 with a primary completion date of 2028-11-14.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Westlake Longevity Cohort (We-Longevity) is a prospective cohort study among centenarians, nonagenarians and senior citizens living in Zhejiang Province, China. The primary aim of this cohort is to characterize the multi-omics molecular characteristics of healthy longevity and their dynamic trajectories. The second aim is to culture the gut microbiota of these elderly people through culturomics. The third aim of We-Longevity is to investigate the association of dietary and lifestyle with the multi-omics molecular characteristics of healthy longevity, and to facilitate the development of personalized nutritional/lifestyle recommendation for the public.
Eligibility Criteria
Inclusion Criteria: * Participants live in Zhejiang Province, China. * Participants intend to remain in Zhejiang Province for ≥3 years. Exclusion Criteria: * Participants with infectious diseases.
Contact & Investigator
Ju-Sheng Zheng, PhD
PRINCIPAL INVESTIGATOR
Westlake University
Frequently Asked Questions
Who can join the NCT05256251 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05256251 currently recruiting?
Yes, NCT05256251 is actively recruiting participants. Contact the research team at zhengjusheng@westlake.edu.cn for enrollment information.
Where is the NCT05256251 trial being conducted?
This trial is being conducted at Lishui, China.
Who is sponsoring the NCT05256251 clinical trial?
NCT05256251 is sponsored by Westlake University. The principal investigator is Ju-Sheng Zheng, PhD at Westlake University. The trial plans to enroll 2,800 participants.